检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:贾西 张进安 Jia Xi;Zhang J in'an.(Department of Endocrinology, J inshan Hospital of Fudan University, Shanghai 201508, China)
机构地区:[1]上海复旦大学附属金山医院内分泌科,201508 [2]上海健康医学院附属周浦医院内分泌科-风湿科,201318
出 处:《国际生物制品学杂志》2018年第2期81-85,共5页International Journal of Biologicals
基 金:国家自然科学基金(81471004,81670722)
摘 要:【摘要】T细胞受体(T cell receptor,TCR)是T细胞识别抗原和诱导免疫应答的基础。在自身免疫病状态下,T细胞根据疾病特异性抗原可产生相应的特异性TCR库克隆扩增。通过高通量分子溯序技术检测TCR序列,找出疾病状态下和健康人中TCR库的差异,可进一步探索疾病的发病机制,并为进一步通过诱导免疫耐受干预疾病的发生发展提供了可能。此文概述了近5年来TCR测序和自身免疫病之间的原始研究,并对相关研究进展进行了总结。T cell receptor (TCR) is the basic structure for T lymphocyte to recognize variable antigens and induce immune response. In the state of autoimmune disease, specific clones of T cells with corresponding TCR repertoire are amplified based on specific antigens of the disease. Detection of TCR sequences by high-throughput sequencing technology and identification of TCR repertoire differences between patients and healthy people are novel methods to explore the pathogenesis of diseases. More importantly, it provides a possibility to prevent the initiation and development of diseases through inducing immune tolerance. This review describes original studies about TCR sequencing in autoimmune diseases in the past 5 years, and summarizes its research progress.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15